Stocktwits on MSN
Regenxbio says its gene therapy for muscle disorder showed no evidence of liver injury in study
The only drug-related adverse events observed are typically anticipated with gene therapy administration, the company noted. ・It added that a proactive, short-course immune modulation regimen in ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果